Authors:
I. Benkovský Comenius University Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy Odbojárov 10 832 32 Bratislava Slovakia

Search for other papers by I. Benkovský in
Current site
Google Scholar
PubMed
Close
and
R. Staník Comenius University Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy Odbojárov 10 832 32 Bratislava Slovakia

Search for other papers by R. Staník in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

Labelling of meso-2,3-dimercaptosuccinic acid (DMSA) with technetium-99m was reinvestigated. Dependence of the 99mTc-DMSA complex formation on the molar ratio of DMSA:reducing agent (SnCl2·2H2O) and pH was studied. Five different types of 99mTc-DMSA complexes were determined. Especially three different complexes were established in the clinically used and prepared DMSA kit labelled with 99mTc under alkaline condition. This radiopharmaceutical is used as imaging agent of the primary medullary carcinoma in the thyroid gland and different metastasis types. The existence of all complexes was observed by paper chromatography, paper electrophoresis and high performance liquid chromatography.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)